Yahoo
NasdaqCM - Nasdaq Real Time Price USD

The Oncology Institute, Inc. (STLN)

3.6200 -3.0800 (-45.97%)
At close: November 6 at 4:00:00 PM EST
3.6300 +0.0100 (+0.28%)
After hours: November 6 at 7:18:59 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
587,244
502,729
393,412
324,239
252,483
Cost of Revenue
495,079
426,294
339,415
264,666
200,390
Gross Profit
92,165
76,435
53,997
59,573
52,093
Operating Expense
118,255
112,518
114,115
119,724
124,100
Operating Income
-26,090
-36,083
-60,118
-60,151
-72,007
Net Non Operating Interest Income Expense
-7,629
-11,276
-7,496
-6,777
-4,082
Other Income Expense
-2,574
-13,378
2,951
-16,176
75,998
Pretax Income
-36,293
-60,737
-64,663
-83,104
-91
Tax Provision
0
-131
0
-36
-243
Net Income Common Stockholders
-30,563
-50,305
-53,005
-67,877
68
Average Dilution Earnings
--
--
--
0
-17,048
Diluted NI Available to Com Stockholders
-30,563
-50,305
-53,005
-67,877
-16,980
Basic EPS
-0.29
-0.54
-0.71
-0.92
0.02
Diluted EPS
-0.29
-0.54
-0.71
-0.92
-0.20
Basic Average Shares
101,001.4880
92,389.3810
75,043.6780
73,748.6600
72,793.4970
Diluted Average Shares
101,001.4880
92,389.3810
75,043.6780
73,748.6600
80,605.6000
Total Operating Income as Reported
-26,090
-36,083
-60,118
-77,018
-81,951
Total Expenses
613,334
538,812
453,530
384,390
324,490
Net Income from Continuing & Discontinued Operation
-36,293
-60,606
-64,663
-83,068
152
Normalized Income
-33,159
-48,179.1513
-67,979
-67,602.7023
-59,490.6300
Interest Expense
7,629
11,276
7,496
6,777
4,082
Net Interest Income
-7,629
-11,276
-7,496
-6,777
-4,082
EBIT
-28,664
-49,461
-57,167
-76,327
3,991
EBITDA
-21,855
-42,517
-50,880
-70,454
8,402
Reconciled Cost of Revenue
495,079
426,294
339,415
264,666
200,390
Reconciled Depreciation
6,809
6,944
6,287
5,873
4,411
Net Income from Continuing Operation Net Minority Interest
-36,293
-60,606
-64,663
-83,068
152
Total Unusual Items Excluding Goodwill
-3,134
-12,453
3,316
-15,472
75,497
Total Unusual Items
-3,134
-12,453
3,316
-15,472
75,497
Normalized EBITDA
-18,721
-30,064
-54,196
-54,982
-67,095
Tax Rate for Calcs
0
0
0
0
0.0002
Tax Effect of Unusual Items
0
-26.1513
0
-6.7023
15,854.3700
12/31/2022 - 6/4/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: